Literature DB >> 31026716

Prognostic factors for persistent pain after a first episode of nonspecific idiopathic, non-traumatic neck pain: A systematic review.

Martine Verwoerd1, Harriet Wittink2, Francois Maissan2, Edwin de Raaij2, Rob J E M Smeets3.   

Abstract

BACKGROUND: Prognosis of acute idiopathic neck pain is poor. An overview of modifiable and non-modifiable prognostic factors for the development of chronic musculoskeletal neck pain after an episode of idiopathic, non-traumatic neck pain is needed.
OBJECTIVE: Identify prognostic factors for pain intensity and perceived non-recovery at three, six and 12 months after a first episode of idiopathic, non-traumatic neck pain. STUDY
DESIGN: Systematic review
METHODS: Systematic literature search up to October 21, 2017 for prospective prognostic studies with main outcomes perceived non-recovery and pain intensity. The QUIPS was used for quality assessment.
RESULTS: Out of 2737 screened articles six prospective studies with high-risk-of-bias were identified, analyzing 47 and 43 factors for the outcome variables 'pain intensity' and 'perceived non-recovery', respectively. Based on univariate- and multivariate analyses we found moderate evidence for 'age> 40 years' and 'concomitant back pain' to be prognostic for 'pain intensity'. For the outcome 'perceived non-recovery' at 12 months, we found moderate evidence for both 'a previous period of neck pain' and 'accompanying headache' as prognostic variables for persistent pain, based on univariate analysis. No prognostic factor was found which was retained in more than one multivariate analysis for the outcome variable 'perceived non-recovery'. However, the quality of the evidence for these prognostic factors was low to very low.
CONCLUSION: This review identifies prognostic factors for neck pain, of which only a few are modifiable. Further research is needed before drawing definite conclusions about the prognostic value of these factors.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chronic neck pain; Idiopathic neck pain; Prognostic factors; Systematic review

Year:  2019        PMID: 31026716     DOI: 10.1016/j.msksp.2019.03.009

Source DB:  PubMed          Journal:  Musculoskelet Sci Pract        ISSN: 2468-7812            Impact factor:   2.520


  5 in total

1.  The association between different outcome measures and prognostic factors in patients with neck pain: a cohort study.

Authors:  Birgitte Lawaetz Myhrvold; Alice Kongsted; Pernille Irgens; Hilde Stendal Robinson; Nina K Vøllestad
Journal:  BMC Musculoskelet Disord       Date:  2022-07-14       Impact factor: 2.562

2.  Recovery trajectories in common musculoskeletal complaints by diagnosis contra prognostic phenotypes.

Authors:  Lene Aasdahl; Fredrik Granviken; Ingebrigt Meisingset; Astrid Woodhouse; Kari Anne I Evensen; Ottar Vasseljen
Journal:  BMC Musculoskelet Disord       Date:  2021-05-19       Impact factor: 2.362

3.  Associations between treatment goals, patient characteristics, and outcome measures for patients with musculoskeletal disorders in physiotherapy practice.

Authors:  Olav Amundsen; Nina Køpke Vøllestad; Ingebrigt Meisingset; Hilde Stendal Robinson
Journal:  BMC Musculoskelet Disord       Date:  2021-02-13       Impact factor: 2.362

4.  Stratified care integrated with eHealth versus usual primary care physiotherapy in patients with neck and/or shoulder complaints: protocol for a cluster randomized controlled trial.

Authors:  Mark L van Tilburg; Corelien J J Kloek; Martijn F Pisters; J Bart Staal; Johanna M van Dongen; Marjolein de Weerd; Raymond W J G Ostelo; Nadine E Foster; Cindy Veenhof
Journal:  BMC Musculoskelet Disord       Date:  2021-02-05       Impact factor: 2.362

5.  Consensus of potential modifiable prognostic factors for persistent pain after a first episode of nonspecific idiopathic, non-traumatic neck pain: results of nominal group and Delphi technique approach.

Authors:  Martine Verwoerd; Harriet Wittink; Francois Maissan; Rob Smeets
Journal:  BMC Musculoskelet Disord       Date:  2020-10-07       Impact factor: 2.362

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.